학술논문
Comparative effectiveness of 8 versus 12 weeks of Ombitasvir/Paritaprevir/ritonavir and Dasabuvir in treatment-naïve patients infected with HCV genotype 1b with non-advanced hepatic fibrosis
Document Type
Article
Author
Zarębska-Michaluk, Dorota; Piekarska, Anna; Jaroszewicz, Jerzy; Klapaczyński, Jakub; Mazur, Włodzimierz; Krygier, Rafał; Belica-Wdowik, Teresa; Baka-Ćwierz, Barbara; Janczewska, Ewa; Pabjan, Paweł; Dobracka, Beata; Lorenc, Beata; Tudrujek-Zdunek, Magdalena; Tomasiewicz, Krzysztof; Sitko, Marek; Garlicki, Aleksander; Czauż-Andrzejuk, Agnieszka; Citko, Jolanta; Dybowska, Dorota; Halota, Waldemar; Pawłowska, Małgorzata; Laurans, Łukasz; Deroń, Zbigniew; Buczyńska, Iwona; Simon, Krzysztof; Białkowska, Jolanta; Tronina, Olga; Flisiak, Robert
Source
In Advances in Medical Sciences March 2020 65(1):12-17
Subject
Language
ISSN
1896-1126